These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 15614845)

  • 41. Screening for fetal abnormalities with ultrasound.
    Flood K; Malone FD
    Curr Opin Obstet Gynecol; 2008 Apr; 20(2):139-45. PubMed ID: 18388813
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nuchal translucency and its relationship to congenital heart disease.
    Devine PC; Simpson LL
    Semin Perinatol; 2000 Oct; 24(5):343-51. PubMed ID: 11071375
    [TBL] [Abstract][Full Text] [Related]  

  • 43. First trimester increased nuchal translucency associated with fetal achondroplasia.
    Tonni G; Ventura A; De Felice C
    Am J Perinatol; 2005 Apr; 22(3):145-8. PubMed ID: 15838748
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Screening performance of first-trimester nuchal translucency for major cardiac defects: a meta-analysis.
    Makrydimas G; Sotiriadis A; Ioannidis JP
    Am J Obstet Gynecol; 2003 Nov; 189(5):1330-5. PubMed ID: 14634564
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nuchal translucency and the risk of congenital heart disease.
    Simpson LL; Malone FD; Bianchi DW; Ball RH; Nyberg DA; Comstock CH; Saade G; Eddleman K; Gross SJ; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; D'Alton ME
    Obstet Gynecol; 2007 Feb; 109(2 Pt 1):376-83. PubMed ID: 17267839
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Elevated first-trimester nuchal translucency increases the risk of congenital heart defects.
    Bahado-Singh RO; Wapner R; Thom E; Zachary J; Platt L; Mahoney MJ; Johnson A; Silver RK; Pergament E; Filkins K; Hogge WA; Wilson RD; Jackson LG;
    Am J Obstet Gynecol; 2005 May; 192(5):1357-61. PubMed ID: 15902108
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early fetal echocardiography and anomaly scan in fetuses with increased nuchal translucency.
    Sairam S; Carvalho JS
    Early Hum Dev; 2012 May; 88(5):269-72. PubMed ID: 22464566
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prenatal screening for serious congenital heart defects using nuchal translucency: a meta-analysis.
    Wald NJ; Morris JK; Walker K; Simpson JM
    Prenat Diagn; 2008 Dec; 28(12):1094-104. PubMed ID: 19009556
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Recent advances in prenatal diagnostics].
    Lapaire O; Holzgreve W; Miny P; Hösli I; Hahn S; Tercanli S
    Ther Umsch; 2006 Nov; 63(11):683-91. PubMed ID: 17075782
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of increased nuchal translucency in fetuses with congenital cardiac disease and a normal karyotype.
    Vogel M; Sharland GK; McElhinney DB; Zidere V; Simpson JM; Miller OI; Allan LD
    Cardiol Young; 2009 Sep; 19(5):441-5. PubMed ID: 19638249
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardiac malformations in first-trimester fetuses with increased nuchal translucency: ultrasound diagnosis and postmortem morphology.
    Haak MC; Bartelings MM; Gittenberger-De Groot AC; Van Vugt JM
    Ultrasound Obstet Gynecol; 2002 Jul; 20(1):14-21. PubMed ID: 12100412
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nuchal translucency-based Down syndrome screening: barriers to implementation.
    Malone FD
    Semin Perinatol; 2005 Aug; 29(4):272-6. PubMed ID: 16104681
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Nuchal translucency: screening for chromosomal abnormalities and congenital malformations. Multicenter study].
    Jemmali M; Valat AS; Poulain P; Favre R; Bourgeot P; Subtil D; Puech F
    J Gynecol Obstet Biol Reprod (Paris); 1999 Oct; 28(6):538-43. PubMed ID: 10598347
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Incidence of major structural cardiac defects associated with increased nuchal translucency but normal karyotype.
    Ghi T; Huggon IC; Zosmer N; Nicolaides KH
    Ultrasound Obstet Gynecol; 2001 Dec; 18(6):610-4. PubMed ID: 11844199
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of nuchal translucency in the screening for congenital heart defects.
    Bruns RF; Moron AF; Murta CG; Gonçalves LF; Zamith MM
    Arq Bras Cardiol; 2006 Sep; 87(3):307-14. PubMed ID: 17057931
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased first-trimester fetal nuchal translucency thickness in association with chondroectodermal dysplasia (Ellis-Van Creveld syndrome).
    Venkat-Raman N; Sebire NJ; Murphy KW; Carvalho JS; Hall CM
    Ultrasound Obstet Gynecol; 2005 Apr; 25(4):412-4. PubMed ID: 15717287
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nuchal translucency.
    Blakemore KJ
    Ultrasound Obstet Gynecol; 1998 Jun; 11(6):388-90. PubMed ID: 9674083
    [No Abstract]   [Full Text] [Related]  

  • 58. Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency.
    Pandya PP; Kondylios A; Hilbert L; Snijders RJ; Nicolaides KH
    Ultrasound Obstet Gynecol; 1995 Jan; 5(1):15-9. PubMed ID: 7850583
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Screening for trisomy 21 by fetal nuchal translucency and maternal age: a multicenter project in Germany, Austria and Switzerland.
    Gasiorek-Wiens A; Tercanli S; Kozlowski P; Kossakiewicz A; Minderer S; Meyberg H; Kamin G; Germer U; Bielicki M; Hackelöer BJ; Sarlay D; Kuhn P; Klapp J; Bahlmann F; Pruggmayer M; Schneider KT; Seefried W; Fritzer E; von Kaisenberg CS;
    Ultrasound Obstet Gynecol; 2001 Dec; 18(6):645-8. PubMed ID: 11844207
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Increased fetal nuchal translucency as a predictor of Cantrell's pentology--case report].
    Staboulidou I; Wüstemann M; Schmidt P; Günter HH; Scharf A
    Z Geburtshilfe Neonatol; 2005 Dec; 209(6):231-4. PubMed ID: 16395641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.